인쇄하기
취소
|
Business sources say that the majority of foreign-invested pharmaceutical firms experienced sluggish growth rates of turnover in 2002 over the previous year and some multinational firms plans to launch new products this year amid uncertain prospect for pharmaceutical business and the government's drug-related policy to discourage the use of high-priced drugs: Details:
Individual per...